News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,915 Results
Type
Article (14276)
Company Profile (281)
Press Release (254358)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (79543)
Career Advice (153)
Deals (13231)
Drug Delivery (35)
Drug Development (50469)
Employer Resources (31)
FDA (5728)
Job Trends (5139)
News (144459)
Policy (10034)
Tag
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21681)
ALS (69)
Alzheimer's disease (851)
Antibody-drug conjugate (ADC) (108)
Approvals (5754)
Artificial intelligence (133)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (232)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (161)
Cancer (1523)
Cardiovascular disease (121)
Career advice (134)
Career pathing (2)
CAR-T (123)
Cell therapy (341)
Cervical cancer (9)
Clinical research (41177)
Collaboration (560)
Compensation (281)
Complete response letters (13)
COVID-19 (1034)
CRISPR (44)
C-suite (172)
Cystic fibrosis (78)
Data (1619)
Denatured (11)
Depression (32)
Diabetes (142)
Diagnostics (1303)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (91)
Earnings (30129)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (48797)
Executive appointments (475)
FDA (6501)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (514)
Gene editing (102)
Generative AI (10)
Gene therapy (265)
GLP-1 (372)
Government (1084)
Grass and pollen (2)
Guidances (70)
Healthcare (6595)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (100)
Indications (20)
Infectious disease (1101)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (18)
IPO (7281)
IRA (11)
Job creations (863)
Job search strategy (127)
Kidney cancer (7)
Labor market (8)
Layoffs (215)
Leadership (3)
Legal (1386)
Liver cancer (34)
Lung cancer (207)
Lymphoma (103)
Machine learning (5)
Management (7)
Manufacturing (148)
MASH (63)
Medical device (2603)
Medtech (2604)
Mergers & acquisitions (6290)
Metabolic disorders (406)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (73)
Neuropsychiatric disorders (25)
Neuroscience (1277)
NextGen: Class of 2025 (2017)
Non-profit (852)
Now hiring (22)
Obesity (197)
Opinion (103)
Ovarian cancer (67)
Pain (45)
Pancreatic cancer (60)
Parkinson's disease (124)
Partnered (8)
Patents (137)
Patient recruitment (83)
Peanut (35)
People (25684)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14548)
Phase II (19160)
Phase III (12099)
Pipeline (947)
Policy (49)
Postmarket research (852)
Preclinical (6161)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (298)
Real estate (1419)
Recruiting (12)
Regulatory (8678)
Reports (16)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (5)
RNA editing (5)
RSV (10)
Schizophrenia (64)
Series A (99)
Series B (69)
Service/supplier (1)
Sickle cell disease (41)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1977)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (12)
The Weekly (37)
Vaccines (217)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (124)
Last 7 days (613)
Last 30 days (1870)
Last 365 days (19385)
2025 (7093)
2024 (20551)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16224)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (43)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17354)
Australia (2944)
California (4074)
Canada (1175)
China (378)
Colorado (153)
Connecticut (156)
Delaware (110)
Europe (37349)
Florida (498)
Georgia (124)
Idaho (16)
Illinois (240)
India (10)
Indiana (94)
Iowa (2)
Japan (79)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (493)
Massachusetts (3249)
Michigan (74)
Minnesota (152)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1012)
New Mexico (12)
New York (1090)
North Carolina (572)
North Dakota (5)
Northern California (1821)
Ohio (115)
Oklahoma (9)
Oregon (21)
Pennsylvania (770)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (5)
Southern California (1561)
Tennessee (25)
Texas (472)
United States (13917)
Utah (56)
Virginia (83)
Washington D.C. (31)
Washington State (362)
Wisconsin (16)
268,915 Results for "foghorn therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference
May 5, 2025
·
1 min read
Press Releases
Foghorn Therapeutics Appoints Neil Gallagher and Stuart Duty to its Board of Directors
May 2, 2025
·
4 min read
Press Releases
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
February 26, 2025
·
1 min read
Press Releases
Foghorn Therapeutics to Host Virtual Investor Event to Review Pipeline Updates in Conjunction with 2025 AACR Annual Meeting
April 16, 2025
·
3 min read
Press Releases
Foghorn Therapeutics Provides Financial Update for 2024 and 2025 Strategic Outlook
March 6, 2025
·
11 min read
Press Releases
Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update
April 28, 2025
·
9 min read
Press Releases
Foghorn Therapeutics Highlights Program Progress and Strategic Objectives for 2025
January 14, 2025
·
7 min read
Genetown
Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June 2024
Foghorn® Therapeutics Inc. announced management’s participation in the Jefferies Global Healthcare Conference and the Goldman Sachs 45th Annual Global Healthcare Conference.
May 28, 2024
·
1 min read
Press Releases
Foghorn Therapeutics Announces New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and EP300 Degrader Programs at 2025 AACR Meeting
March 25, 2025
·
5 min read
Press Releases
Foghorn Therapeutics Provides Update on FHD-286 Clinical Development Program and Strategic Priorities
December 17, 2024
·
4 min read
1 of 26,892
Next
